drugset / Trial / NCT01890785

Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers

NCT01890785

Phase 1 Completed 30 enrolled Shire
RandomizedCrossoverOpen-labelTreatment

Summary

Compare the pharmacokinetic profiles when the contents are emptied into a soft food and orange juice compared to the SPD489 when swallowed as an intact capsule.

Timeline

Start
2013-07-15
Primary completion
2013-08-22
Completion
2013-08-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Lisdexamfetamine Dimesylate Small molecule 70 mg Oral

Indications

No indication recorded.